Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sherette S. Godfrey"'
Autor:
Checo J. Rorie, Sherette S. Godfrey
Publikováno v:
Cancer Prevention Research. 13:A08-A08
Understanding the relationship between heavy metal exposure and triple-negative breast cancer cells may help to elucidate the high breast cancer mortality rate and health disparity in African-American women, as they may be exposed to these heavy meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61a6aa9531faefd2f083525e17456766
https://doi.org/10.1158/1940-6215.envcaprev19-a08
https://doi.org/10.1158/1940-6215.envcaprev19-a08
Autor:
Checo J. Rorie, Sherette S. Godfrey
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:B072-B072
Understanding the relationship between heavy metal exposure and triple-negative breast cancer cells may help to elucidate the high breast cancer mortality rate and health disparity in African-American women, as they may be exposed to these heavy meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7539a147ef349a84837c48c69db654e8
https://doi.org/10.1158/1538-7755.disp18-b072
https://doi.org/10.1158/1538-7755.disp18-b072
Publikováno v:
Journal of Chemical Health Risks, Vol 7, Iss 1 (2017)
The hazardous consequences of heavy metal ions (HMIs) on human health necessitate the immediate need to probe fundamentally the interactions and cytotoxic effects of HMIs on humans. This study investigated the influence of five toxic HMIs (arsenic (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::4ed4b990c80e06a421d920086e5f4e77
http://jchr.org/index.php/JCHR/article/view/720
http://jchr.org/index.php/JCHR/article/view/720
Publikováno v:
Cancer Research. 77:5879-5879
Resistance to chemotherapy is one of the major difficulties in the treatment of triple negative breast cancer. Besides the typical known causes of drug resistance, tumor microenvironment can also promote resistance by preventing the drug from accumul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8131f7ff217a73f73ab90fabf1ecfe8c
https://doi.org/10.1158/1538-7445.am2017-5879
https://doi.org/10.1158/1538-7445.am2017-5879
Publikováno v:
Cancer Research. 76:83-83
“Triple-negative” breast cancer (TNBC) is an aggressive subtype of breast cancer that appears prevalently in African American women below the age of 35, and has no known biomarker that can be targeted for drug therapy. This aggressive breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4395650a95933bbd49cd086080975a85
https://doi.org/10.1158/1538-7445.am2016-83
https://doi.org/10.1158/1538-7445.am2016-83
Autor:
Brianna L. Arrington, Armeshia S. McCoy, Sherette S. Godfrey, Checo J. Rorie, Kashenya M. Gurley
Publikováno v:
Cancer Research. 74:1472-1472
Breast cancer is a heterogenous disease that is the second leading cause of death amongst women in the United States. Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer characterized by its loss of estrogen, progestero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6c027a7c62cdb12342400ad37aadc5
https://doi.org/10.1158/1538-7445.am2014-1472
https://doi.org/10.1158/1538-7445.am2014-1472